GenoFocus Inc
KOSDAQ:187420
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
G
|
GenoFocus Inc
KOSDAQ:187420
|
82B KRW |
Loading...
|
|
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
90.4B USD |
Loading...
|
|
| US |
|
Ecolab Inc
NYSE:ECL
|
86.4B USD |
Loading...
|
|
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
11.1T JPY |
Loading...
|
|
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
269.3B CNY |
Loading...
|
|
| CH |
|
Givaudan SA
SIX:GIVN
|
28.9B CHF |
Loading...
|
|
| US |
|
PPG Industries Inc
NYSE:PPG
|
28.2B USD |
Loading...
|
|
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK |
Loading...
|
|
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.3T INR |
Loading...
|
|
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR |
Loading...
|
|
| US |
|
International Flavors & Fragrances Inc
NYSE:IFF
|
20.9B USD |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
GenoFocus Inc
Glance View
GenoFocus, Inc. engages the research and development of technologies related to biochemical and biotechnology industry. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2015-05-29. The firm mainly manufactures catalases, lactase, phytases and other enzymes. The catalases are mainly used for industry, including processing of semiconductors, petroleum and propylene oxide, medical therapeutics, food processing, contact-lens and other industries. The lactases are mainly used for food processing including processing of milk, yogurt and milk serum. The phytases are mainly used for processing of animal feed. And the Company is exploring new businesses, engaged in development of other enzymes including therapeutic enzymes, chemical agents and others.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for GenoFocus Inc is 38.3%, which is above its 3-year median of 34.4%.
Over the last 3 years, GenoFocus Inc’s Gross Margin has decreased from 40.9% to 38.3%. During this period, it reached a low of 26.3% on Sep 30, 2023 and a high of 40.9% on Sep 30, 2022.
